Intrust Bank Na Charles River Laboratories International, Inc. Transaction History

Intrust Bank Na

$995 Million
Q3 2024

A detailed history of Intrust Bank Na transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Intrust Bank Na holds 2,151 shares of CRL stock, worth $356,635. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,151

Previous 1,993 7.93%

Holding current value

$356,635

Previous $411,000 2.92%

% of portfolio

0.04%

Previous 0.04%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$187.96 - $245.29 $29,697 - $38,755	158 Added 7.93%	2,151 $423,000
Q2 2024 Aug 08, 2024	SELL	$206.39 - $268.73 $8,874 - $11,555	-43 Reduced 2.11%	1,993 $411,000
Q1 2024 May 09, 2024	SELL	$203.52 - $273.43 $36,837 - $49,490	-181 Reduced 8.16%	2,036 $551,000
Q4 2023 Feb 05, 2024	SELL	$164.52 - $238.84 $21,716 - $31,526	-132 Reduced 5.62%	2,217 $524,000
Q3 2023 Nov 13, 2023	SELL	$194.44 - $217.61 $8,749 - $9,792	-45 Reduced 1.88%	2,349 $460,000
Q2 2023 Aug 10, 2023	SELL	$183.71 - $210.25 $42,069 - $48,147	-229 Reduced 8.73%	2,394 $503,000
Q1 2023 May 04, 2023	SELL	$191.89 - $259.92 $71,383 - $96,690	-372 Reduced 12.42%	2,623 $529,000
Q4 2022 Feb 10, 2023	BUY	$197.11 - $250.07 $29,960 - $38,010	152 Added 5.35%	2,995 $652,000
Q3 2022 Nov 09, 2022	SELL	$182.44 - $250.54 $547 - $751	-3 Reduced 0.11%	2,843 $559,000
Q2 2022 Aug 16, 2022	SELL	$204.13 - $302.4 $41,030 - $60,782	-201 Reduced 6.6%	2,846 $609,000
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $25,295 - $35,848	-99 Reduced 3.15%	3,047 $865,000
Q4 2021 Feb 03, 2022	BUY	$351.38 - $448.68 $11,595 - $14,806	33 Added 1.06%	3,146 $1.19 Million
Q3 2021 Nov 04, 2021	SELL	$372.64 - $458.3 $22,358 - $27,498	-60 Reduced 1.89%	3,113 $1.28 Million
Q2 2021 Aug 05, 2021	BUY	$294.17 - $371.65 $11,178 - $14,122	38 Added 1.21%	3,173 $1.17 Million
Q1 2021 Jun 02, 2021	BUY	$249.67 - $299.48 $31,957 - $38,333	128 Added 4.26%	3,135 $909,000
Q4 2020 Feb 10, 2021	BUY	$222.0 - $252.62 $4,440 - $5,052	20 Added 0.67%	3,007 $751,000
Q3 2020 Nov 05, 2020	SELL	$175.56 - $226.45 $1,931 - $2,490	-11 Reduced 0.37%	2,987 $676,000
Q2 2020 Aug 05, 2020	BUY	$118.84 - $189.72 $16,162 - $25,801	136 Added 4.75%	2,998 $522,000
Q1 2020 May 06, 2020	SELL	$98.9 - $178.34 $29,670 - $53,502	-300 Reduced 9.49%	2,862 $361,000
Q4 2019 Feb 07, 2020	BUY	$126.05 - $152.76 $17,142 - $20,775	136 Added 4.49%	3,162 $483,000
Q3 2019 Nov 12, 2019	BUY	$125.07 - $143.67 $3,376 - $3,879	27 Added 0.9%	3,026 $400,000
Q2 2019 Aug 12, 2019	BUY	$123.4 - $148.55 $9,008 - $10,844	73 Added 2.49%	2,999 $425,000
Q1 2019 May 10, 2019	SELL	$104.82 - $146.73 $1,886 - $2,641	-18 Reduced 0.61%	2,926 $425,000
Q4 2018 Feb 06, 2019	BUY	$105.09 - $137.23 $62,948 - $82,200	599 Added 25.54%	2,944 $333,000
Q3 2018 Nov 09, 2018	BUY	$112.11 - $134.54 $31,054 - $37,267	277 Added 13.39%	2,345 $316,000
Q2 2018 Aug 08, 2018	BUY	$102.37 - $117.25 $211,701 - $242,473	2,068 New	2,068 $232,000

Others Institutions Holding CRL

# of Institutions

692

Shares Held

52.1M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.43B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.

Account